Mark Agulnik
Impact in
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
- Oncology top 1%
- Vascular Tumors and Angiosarcomas
- CAR-T cell therapy research
Papers in
-
- Sarcoma Diagnosis and Treatment 63
- Lung Cancer Treatments and Mutations 12
- Oncology 77
- Vascular Tumors and Angiosarcomas 22
- CAR-T cell therapy research 18
- Co-authors
- Lillian L. Siu (8 shared papers)Joel B. Epstein (5 shared papers)Scott H. Okuno (21 shared papers)Gregory R. Pond (6 shared papers)Ari J. Rosenberg (1 shared paper)Margaret von Mehren (10 shared papers)Jessica Lee Yarber (3 shared papers)Bruce Brockstein (4 shared papers)
- Journals
- Journal of Clinical Oncology (50 papers)Annals of Oncology (15 papers)Cancer (5 papers)Cancer Research (4 papers)Cancer Medicine (4 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Mark Agulnik
163 papers receiving 4.4k citations
Mark Agulnik's Hit Papers
Peers
Comparison fields: 5 of 116
- Otorhinolaryngology 520
- Oncology 2.0k
- Pulmonary and Respiratory Medicine 1.7k
- Pathology and Forensic Medicine 380
- Cancer Research 312
Countries citing papers authored by Mark Agulnik
This map shows the geographic impact of Mark Agulnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Agulnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Agulnik more than expected).
Fields of papers citing papers by Mark Agulnik
This network shows the impact of papers produced by Mark Agulnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Agulnik. The network helps show where Mark Agulnik may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Agulnik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 172 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial Hit paper breakdown → | 2016 | 456 |
| 2 | 2012 | 300 | |
| 3 | 2007 | 216 | |
| 4 | 2007 | 200 | |
| 5 | 2019 | 186 | |
| 6 | 2008 | 130 | |
| 7 | 2009 | 128 | |
| 8 | 2021 | 112 | |
| 9 | 2018 | 105 | |
| 10 | 2011 | 104 | |
| 11 | 2016 | 104 | |
| 12 | 2012 | 93 | |
| 13 | 2013 | 92 | |
| 14 | 2016 | 91 | |
| 15 | Head and neck cancer: changing epidemiology and public health implications. | 2010 | 86 |
| 16 | 2006 | 81 | |
| 17 | 2007 | 72 | |
| 18 | 2013 | 67 | |
| 19 | 2009 | 67 | |
| 20 | 2007 | 66 |
About Mark Agulnik
Mark Agulnik is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Pathology and Forensic Medicine and Otorhinolaryngology, having authored 172 papers that have together received 4.5k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (63 papers), Head and Neck Cancer Studies (23 papers), Vascular Tumors and Angiosarcomas (22 papers), CAR-T cell therapy research (18 papers), Lymphoma Diagnosis and Treatment (15 papers), Salivary Gland Tumors Diagnosis and Treatment (14 papers), Gastrointestinal Tumor Research and Treatment (13 papers) and Lung Cancer Treatments and Mutations (12 papers). The work is most often cited by research in Otorhinolaryngology (520 citations), Oncology (2.0k citations), Pulmonary and Respiratory Medicine (1.7k citations), Pathology and Forensic Medicine (380 citations) and Cancer Research (312 citations). Mark Agulnik has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Lillian L. Siu, Joel B. Epstein, Scott H. Okuno, Gregory R. Pond, Ari J. Rosenberg, Margaret von Mehren, Jessica Lee Yarber, Bruce Brockstein, Brian A. Van Tine and Mario E. Lacouture. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, Cancer Research and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.